Volume 7, Issue 1 (5-2019)                   jms 2019, 7(1): 91-78 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

M N, S S. New Aspects of Bilirubin Effects in Health and Disease: a Review. jms. 2019; 7 (1) :91-78
URL: http://jms.thums.ac.ir/article-1-556-en.html
1- Departments of Biochemistry, School of Medicine, Shiraz University of Medical Sciences
Abstract:   (2355 Views)
Bilirubin belongs to a phylogenetically old superfamily of tetrapyrrolic compounds. Although for decades bilirubin was believed to be only a waste product of the heme catabolic pathway and a potentially toxic compound; recent data has convincingly demonstrated that mildly elevated serum bilirubin levels are strongly associated with a lower prevalence of oxidative stress-mediated diseases, such as cardiovascular diseases (CVD), diabetes, cancer and all-cause mortality. Therefore, bilirubin is emerging as a ‘health- promoting’ molecule and the role of bilirubin as a biological predictor in the risk assessment of chronic disorders is of great medical and economic importance. In the present review, detailed information on the association between bilirubin and all-cause mortality, as well as the pathological conditions of CVD, cancer, diabetes, neurodegenerative diseases, non-alcoholic fatty liver disease and organ transplantation is provided. All of these pathological conditions represent an important threat to human civilization, being the major killers in developed countries, with a steadily increasing prevalence. Thus, it is extremely important to search for novel markers of these diseases, as well as for finding new therapeutic modalities to reverse this unfavorable situation. Thus, it is suggested to consider bilirubin in clinical trials as a molecule which may be involved in resistance to diseases. 
Keywords: Bilirubin, Health, Diseases
Full-Text [PDF 295 kb]   (3475 Downloads)    
Type of Study: Research | Subject: Special
Received: 2018/11/23 | Accepted: 2019/06/2 | Published: 2019/09/14

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Designed & Developed by : Yektaweb